3Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2N0 Squamous Cell Carcinoma of the Glottie Larynx Treated With Radiation Therapr [J]. J Clin Oncol, 2001, 19: 4029-4036. 被引量：1
4Jin J, Liao ZX, Gao L, et al. Analysis of prognostic facters for TINOMO glottic cancers treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of sciences[J]. Int J Radiat Oncol Biol Phys,2002, 54:471-478. 被引量：1
6Vandenbrouck C, Sancho H, R Le Fur, et al. Result of randomized clinical trial of preoperative irradiation versus post operative in treatment of tumors of the hypopharyn[J]. Cancer, 1997,39:1445-1449. 被引量：1
8Marcial VA,Gelber R. Does preoperative irradiation increse the rate of surgical complications in carcinoma of the head and: a RTOG repent [J]. ancer, 1982, 49:1297-1301. 被引量：1
9Tupchong L, Scott CB, Blitzer BH, et al. Randomized study of preoperative versus radiation therapy in advanced head and neck carcinoma:long-term follow-up of RTOG study 73-03[J]. Int J Radiat Oncol Biol Phys, 1991,20:21-28. 被引量：1
2[4]JP Xiao, GZ Xu, YJ Miao. Fractionated stereotactic radio therapy for 50 patients with recurrent or residual nasopharyngeal carcinoma [J]. Int J Rad Oncol Biol Phys, 2001, 51(1):164-170. 被引量：1
3[5]Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2003, 56(4):1046-1054. 被引量：1
4[6]N Lee, P Xia, JM Quivey, et al. Intensity-modulated ra diotherapy in the treatment of nasopharyngeal carcinoma: an update of USCF experience [J].J Radiat Oncol Biol Phys, 2002, 53(1):12-22. 被引量：1
5[10]CH Shu, H Cheng, JF Lirng, et al. Salvage surgery for recurrent nasopharyngeal carcinoma[J]. The Laryngoscope, 2000,110(9): 1483-1488. 被引量：1
6[11]WWK King, PKM Ku, C Mork, et al. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience[J]. Head and Neck, 2000, 22(3): 215-222. 被引量：1
7[12]International nasopharynx cancer study group. Preliminary results of a randomized trial comparing neoadjurant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in satge Ⅳ(≥N2M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival [J]. Int J Radiat Oncol BiolPhys, 1996,3 5:463-469. 被引量：1
8[13]Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy along in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharyngeal Cancer Study Group[J]. Cancer, 1998, 83(11):2270-2283. 被引量：1
9[15]Chua DT, Sham JS, Wei WI, et al. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma[J]. Head Neck, 2002, 24 (4):350-360. 被引量：1
10[16]Lin JC, Jan JS, Liang WM, et al. Phase Ⅲstudy of concurrent chemoradiotherapy versus radiotherapy alone for ad vanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival [J]. J Clin Oncol, 2003 , 21:631-637. 被引量：1
